Alterations of Liver Function Test in Patients Treated with Antipsychotics

Journal of Clinical Laboratory Analysis

Volumn 17, Issue 6, 2003, Pages 216-218

  Garcia Unzueta, M Teresa ^a   Herran, Andres ^a   Sierra Biddle, Deirdre ^a   Amado, J Antonio ^a   Vázquez Barquero, J Luis ^a   Álvarez, Concepción ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antipsychotics; Liver function tests; Neuroleptics; Schizophrenia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BILIRUBIN; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; FLUPHENAZINE; GAMMA GLUTAMYLTRANSFERASE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA;

ALANINE TRANSAMINASE; ALBUMINS; ALKALINE PHOSPHATASE; ANTIPSYCHOTIC AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0347589504     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10094     Document Type: Article

References (11)

1. Derby LE, Pérez Gutthann S, Jick H, Dean AD. Liver disorders in patients receiving chlorpromazine or isoniazid. Pharmacotherapy 1993;13:353-358.
2. Hansen TE, Casey DE, Hoffman WF. Neuroleptic intolerance. Schizophr Bull 1997;23:567-582.
3. Selim K, Kaplowitz N. Hepatotoxicity of psychotropic drugs. Hepatology 1999;29:1347-1351.
4. Holt RJ. Fluphenazine decanoate-induced cholestatic jaundice and thrombocytopenia. Pharmacotherapy 1984;4:227-229.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Wahington, DC: APA; 1994.
6. Wing JK, Babor T, Brugha T, et al. SCAN: schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
7. Vázquez-Barquero JL, Gaite L, Artal J, et al. Desarrollo y Verificación de la Versión Española de la Entrevista Psiquiátrica "Sistema SCAN" (Cuestionarios para la Evaluación Clinica en Neuropsiquiatría). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1994;22:109-120.
8. Bech P, Malt UF, Dencker SJ, et al. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993;87(suppl 37):30-31.
9. Kay SR. Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
10. Obata T. Intrahepatic cholestasis and hyperbilirubinemia in ethynyl estradiol and chlorpromazine-treated rats. Gastroenterol Jpn 1983;18:538-548.
11. Cepelak I, Lipovac K, Juretic D, Birek Z. Effects of neuroleptic phenothiazines on the activities of aminotransferases and gamma-glutamyltransferase in serum and liver. J Clin Chem Clin Biochem 1986;24:583-587.